Targeted discovery of gut microbiome-remodeling compounds for the treatment of systemic inflammatory response syndrome/Experiment 13/Signature 1
From BugSigDB
Reviewed Marked as Reviewed by Svetlana up on 2024-12-9
Source: Figure S5D
Description: The relative abundance in genus levels after cocktail treatment
Abundance in Group 1: decreased abundance in A2.2(gut microbiome remodeling compound)
NCBI | Quality Control | Links |
---|---|---|
Bacteroides | ||
Escherichia/Shigella sp. |
Revision editor(s): Ifeanyisam